17th International Congress on Infectious Diseases
17thICID_FinalProg
17thICID_FinalProg
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<str<strong>on</strong>g>17th</str<strong>on</strong>g> INTERNATIONAL CONGRESS ON INFECTIOUS DISEASES<br />
Scientific Program ~ Thursday, March 3, 2016<br />
Sessi<strong>on</strong> 04 CME<br />
Symposium<br />
Diagnosis and Treatment of<br />
Carbapenem-resistant<br />
Enterobacteriaceae<br />
Co-Chairs: Didier Pittet, Switzerland<br />
Tetsuya Matsumoto, Japan<br />
Room: Hall 5 10:15–12:15<br />
Ground Floor Thursday, March 3, 2016<br />
04.001 N<strong>on</strong>-molecular detecti<strong>on</strong> of carbapenemases<br />
in Enterobacteriaceae clinical isolates<br />
L. Martinez-Martinez<br />
Santander (Spain)<br />
04.002 Molecular diagnosis of carbapenemase<br />
producing Enterobacteriaceae infecti<strong>on</strong><br />
Y. Ishii<br />
Tokyo (Japan)<br />
04.003 C<strong>on</strong>trol of carbapenem-resistant<br />
Enterobacteriaceae<br />
S. Munoz-Price<br />
Milwaukee, WI (USA)<br />
04.004 Appropriate therapy for carbapenem-resistant<br />
Enterobacteriaceae (CRE)<br />
O.C. Abraham<br />
Vellore (India)<br />
In collaborati<strong>on</strong> with the Japanese Associati<strong>on</strong><br />
for <strong>Infectious</strong> <strong>Diseases</strong><br />
Sessi<strong>on</strong> 05<br />
Integrated Symposium<br />
Antifungal Prophylaxis or Treatment:<br />
Why, When & What?<br />
Co-Chairs: Ant<strong>on</strong>io Pagliuca, United Kingdom<br />
Alok Srivastava, India<br />
Room: Hall 6 10:15–12:15<br />
Ground Floor Thursday, March 3, 2016<br />
05.001 Making clinical sense of Candida and<br />
Aspergillus susceptibilities<br />
N. Wiederhold<br />
San Ant<strong>on</strong>io, TX (USA)<br />
05.002 Why prophylaxis for IFI?<br />
A. Pagliuca<br />
L<strong>on</strong>d<strong>on</strong> (United Kingdom)<br />
05.003 Risk stratificati<strong>on</strong> for treatment or prophylaxis<br />
of invasive fungal infecti<strong>on</strong>s<br />
M. Slavin<br />
Melbourne (Australia)<br />
05.004 New opti<strong>on</strong>s for preventi<strong>on</strong> and treatment<br />
of IFI<br />
R. Duarte<br />
Madrid (Spain)<br />
Sp<strong>on</strong>sored by MSD<br />
Sessi<strong>on</strong> 06 CME<br />
Symposium<br />
HIV-Management of Opportunistic<br />
Infecti<strong>on</strong>s in Low- and Middle-Income<br />
Countries<br />
Co-Chairs: Adeeba Kamarulzaman, Malaysia<br />
N. Kumarasamy, India<br />
Room: G.01–03 10:15–12:15<br />
Ground Floor Thursday, March 3, 2016<br />
06.001 Tuberculosis/HIV co-infecti<strong>on</strong><br />
S. Swaminathan<br />
Chennai (India)<br />
06.002 Cryptococcal meningitis and bey<strong>on</strong>d—<br />
Management of select opportunistic<br />
infecti<strong>on</strong>s in Sub-Saharan Africa<br />
G. Meintjes<br />
Cape Town (South Africa)<br />
06.003 Challenges in the management of<br />
opportunistic infecti<strong>on</strong>s: Focus <strong>on</strong><br />
Southeast Asia<br />
A. Kamarulzaman<br />
Kuala Lumpur (Malaysia)<br />
06.004 The challenge of opportunistic infecti<strong>on</strong>s:<br />
Focus <strong>on</strong> South America<br />
J. Torres<br />
Caracas (Venezuela)<br />
Sessi<strong>on</strong> 07 CME<br />
Symposium<br />
One Health and Emerging<br />
<strong>Infectious</strong> <strong>Diseases</strong><br />
Co-Chairs: Larry Madoff, USA<br />
Ali Benkirane, Morocco<br />
Room: G.05–06 10:15–12:15<br />
Ground Floor Thursday, March 3, 2016<br />
07.001 Mers-CoV: From camels to humans<br />
Z. Memish<br />
Riyadh (Saudi Arabia)<br />
THURSDAY • March 3, 2016<br />
#<str<strong>on</strong>g>17th</str<strong>on</strong>g>ICID FINAL PROGRAM ~ 29
Change language